Cindy Hoffmeier Channing J. Der, Der lab, Kirsten Bryant, PanCAN, pancreatic cancer, Pancreatic Cancer Action Network, Purple Stride, UNC, UNC Lineberger

Photos from Purple Stride 2016

PurpleStride is the signature event of the Pancreatic Cancer Action Network. Each year, in communities across the country, tens of thousands of people participate in more than fifty-six PurpleStride events, including PurpleStride Raleigh-Durham. These events are critical in raising awareness and funds that advance research and support patients and loved ones with a promise of … Continue reading Photos from Purple Stride 2016

channing der, lineberger
Cindy Hoffmeier Channing J. Der, ERK, Ras, symposium, Translational Medicine, UNC Lineberger

Researchers extract cancer cells’ ‘deadly secrets’ at UNC Lineberger symposium

Researchers from around the country convened in Chapel Hill April 11-12 for UNC Lineberger’s Scientific Symposium to hear the latest research into molecularly targeted treatments for cancer. More than 440 people attended the symposium, the 40th annual, at The William and Ida Friday Center for Continuing Education. Called “Molecularly Targeted Cancer Therapies from Bench to Bedside,” … Continue reading Researchers extract cancer cells’ ‘deadly secrets’ at UNC Lineberger symposium

Cindy Hoffmeier Channing J. Der, Kirsten Bryant, PanCAN, pancreatic cancer, Pancreatic Cancer Action Network

UNC Lineberger researchers driven to fight pancreatic cancer

Kirsten Bryant, PhD, a cancer researcher and postdoctoral fellow at the UNC Lineberger Comprehensive Cancer Center, and Channing Der, PhD, a UNC Lineberger member and the Sarah Graham Kenan Professor of Pharmacology, shared personal stories of why they're driven to fight pancreatic cancer at a breakfast in Durham on Tuesday. See the full article here: https://unclineberger.org/news/unc-lineberger-researchers-driven-to-fight-pancreatic-cancer?utm_source=lineup&utm_medium=email&utm_campaign=10 

Cindy Hoffmeier Channing J. Der, Der lab, lab, pancreatic cancer, Purple Stride, Ras, Ras protein superfamily, research

Purple is the New Black

Dr. Channing Der and the rest of the lab were featured in an article on the Carolina Scientific blog.  The article highlights the science the lab is developing as well as the motivation behind the work for many members of the lab.  To see the full article visit the Carolina Scientific website here: http://www.carolinascientific.org/blog/2016/3/6/karriuinq0hkifsfj50nznalaiqxup The Carolina … Continue reading Purple is the New Black

Cindy Hoffmeier Adrienne Cox, Cancer Cell, Channing J. Der, Der lab, KRAS, pancreatic cancer, Tikvah Hayes

Promising direction for the treatment of pancreatic cancers driven by KRAS mutation

University of North Carolina Lineberger Comprehensive Cancer Center researchers have found a promising strategy that may limit the growth of pancreatic cancers in patients with a mutation in a gene called KRAS. More than 95 percent of pancreatic cancers have KRAS mutations, and there's strong evidence that blocking the gene's function could be a very … Continue reading Promising direction for the treatment of pancreatic cancers driven by KRAS mutation

Cindy Hoffmeier Adrienne Cox, Channing J. Der, Der lab, Duke, FIMM, grant, KRAS, NCI

Cox and Der lead team to $2M+ NCI U01 grant

A research team led by Drs. Adrienne D. Cox and Channing J. Der (members of the UNC Lineberger Program in Molecular Therapeutics) is one of the first recipients of an NCI U01 grant on New Approaches to Synthetic Lethality for Mutant KRas-Dependent Cancers. Their team, which also includes Drs. Ben Major at UNC, Kris Wood … Continue reading Cox and Der lead team to $2M+ NCI U01 grant

Cindy Hoffmeier AACR, Aaron Hoobs, ACS, Angelina Vaseva, Channing J. Der, Der lab, grant, Kirsten Bryant, NIH

New Grants awarded in the Der Lab

Channing Der awarded NCI grant to pursue drug discovery Channing J. Der, PhD, UNC Lineberger member and Kenan Distinguished Professor in the Department of Pharmacology at the UNC School of Medicine, was awarded a five-year NIH R01 grant entitled "Biological Activity of RAS Oncogenes". This grant will support his studies to pursue drug discovery for … Continue reading New Grants awarded in the Der Lab

Cindy Hoffmeier after hours, Channing J. Der, Der lab, Leanna Gentry, PhD Defense

Leanna Gentry defends phd thesis

On September 3rd Leanna Gentry, from the Department of Pharmacology, defended her thesis entitled “Targeting the Ras-Ral effector pathway for cancer treatment."  Leanna is the 23rd graduating member of the Der Lab, and will continue her scientific pursuits as she begins work at CATO Research.  After the defense the Lab members treated Leanna to a fabulous … Continue reading Leanna Gentry defends phd thesis

Cindy Hoffmeier Channing J. Der, conference, ovarian cancer, Ras

Dr. Der presents Distinguished Lecture at International Ovarian Cancer Consortium

Dr. Channing Der attended and presented a Distinguished Lecture at the Second Annual Meeting of the International Ovarian Cancer Consortium in conjunction with International Symposium on Tumor Microenvironment and Therapy Resistance August 16 - 18 .  Dr. Der's lecture, entitled " Targeting RAS for Cancer Treatment: Mission Possible?" kicked off the second day of this fabulous conference.  The Stephenson Cancer … Continue reading Dr. Der presents Distinguished Lecture at International Ovarian Cancer Consortium